Edesa Biotech, Inc.
Pharmaceutical Preparations company (SEC registrant, Nasdaq: EDSA)
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 10 annual filings
Revenue
$0.00
Net Income
-$7.19M
Assets
$13.53M
EPS (diluted)
$-1.27
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2021-09-30 · accession
0001654954-21-013551Summary
Key Facts
- Edesa Biotech, Inc.'s headquarters location is recorded as Markham[1].
- Edesa Biotech, Inc.'s ticker symbol is recorded as EDSA[2].
- Edesa Biotech, Inc.'s stock exchange is recorded as Nasdaq[3].
- Edesa Biotech, Inc.'s industry is recorded as Pharmaceutical Preparations[4].
- Edesa Biotech, Inc.'s official name is recorded as Edesa Biotech, Inc.[5].
- Edesa Biotech, Inc.'s nickname is recorded as Stellar Biotechnologies, Inc.[6].
- Edesa Biotech, Inc.'s 4ort:sic is recorded as 2834[7].
- Edesa Biotech, Inc.'s 4ort:fiscal_year_end is recorded as 0930[8].
- Edesa Biotech, Inc.'s 4ort:last_filing_date is recorded as 2026-08-20[9].
- Edesa Biotech, Inc.'s 4ort:state_of_incorporation is recorded as A1[10].
Body
Identity
Edesa Biotech, Inc.'s official name is recorded as Edesa Biotech, Inc.[5].
Operations
Edesa Biotech, Inc.'s headquarters location is recorded as Markham[1].
Industry
Edesa Biotech, Inc.'s industry is recorded as Pharmaceutical Preparations[4].
Ownership
Edesa Biotech, Inc.'s stock exchange is recorded as Nasdaq[3].